Management of Local Anesthetic Toxicity

advertisement

Local Anesthetics

Toxicity and Management

Gregory Pate, MD

Department of Anesthesia

Bremerton Naval Hospital

Local Anesthetic Toxicity Topics

Local Anesthetic Pharmacology

Adverse Reactions to Local Anesthetics

Types of Toxicity

Acute Systemic Toxicity

Management of Acute Systemic Toxicity

Basics: Local Anesthetic Pharm

Amino esters and

Amino amides

Metabolism

Protein binding

Lipophilichydrophilic balance

Hydrogen Ion concentration

Katzung, Basic & clinical pharm,

10 th edition

Basics: Local Anesthetic Mechanism

Active form of the local anesthetic

Modulated receptor theory

Other possible mechanisms of action

Miller’s Anesthesia, 6 th edition

Local Anesthetic Toxicity Topics

Local Anesthetic Pharmacology

Adverse Reactions to Local

Anesthetics

Types of Toxicity

Acute Systemic Toxicity

Management of Acute Systemic Toxicity

Methemoglobinemia

Prilocaine and Benzocaine

Benzocaine sprays like Cetacaine

EMLA cream which has prilocaine although this practice is still generally considered safe

Seen with use of prilocaine in epidurals around at 500-600mg for adults

Dapsone, antibiotics, nitrates, etc.

Methemoglobin related to local anesthetics, Guay et al, 2009

Methemoglobinemia

Hypersensitivity Reactions

IgE mediated vs Non-IgE mediated

Perioperative anaphylaxis about 1:10,000 cases-NMBD, antibiotics, latex

Does not take much allergen

True allergy to amides very rare

True allergy to esters like cocaine, procaine, chloroprocaine more common

Anaphylaxis and Anesthesia,

Dewachter, 2009

Features of Anaphylaxis

Airway: stridor, hoarseness, laryngeal edema, dyspnea, cyanosis, bronchospasm, and obstruction

Cardiac: tachycardia, hypotension, arrhythmia, cardiac arrest

Neuro: dizzy, weak, syncopal, seizure

Skin: flushing, erythema, pruritis, angioedema, maculopapular rash

Diagnoss and Management of

Anaphylaxis, CMAJ, 2003

Acute Anaphylaxis

Diagnoss and Management of

Anaphylaxis, CMAJ, 2003

Biphasic Anaphylaxis

Diagnoss and Management of

Anaphylaxis, CMAJ, 2003

Local Anesthetic Toxicity Topics

Local Anesthetic Pharmacology

Adverse Reactions to Local Anesthestics

Types of Toxicity

Acute Systemic Toxicity

Management of Acute Systemic Toxicity

Types of Local Anesthetic Toxicity

LOCALIZED TOXICITY

Neurotoxicity

Myotoxicity

SYSTEMIC TOXICITY

CNS toxicity

CVS toxicity

Neurotoxicity

Dose/concentration

Duration of nerve exposure

Most common with continuous spinal anesthesia

All amino amides/ amino esters can cause direct toxicity

American Journal of Therapeutics, Cont

Spinal Anesthesia, Moore, 2009

Myotoxicity

Edema and necrosis after exposure to

Lidocaine

Normally limited and reversible

Often reported in

Ophthalmology

Zink et al., 2005

Prevention of LA toxicity

Dosing is a key factor in prevention

Review Therapeutic

Index

Local Anesthetic Toxicity Topics

Local Anesthetic Pharmacology

Adverse Reactions to Local Anesthetics

Types of Toxicity

Acute Systemic Toxicity

Management of Acute Systemic Toxicity

LA toxicity - CNS

Local Anesthetics readily cross the blood-brain barrier

CNS toxicity is drug/dose dependent

Clinical indicators of CNS toxicity

Kreitzer, Journal of Clinical

Anesthesia, 1996

Dose Dependent Systemic Effects

Effects of Lidocaine by plasma concentration

CONC(mcg/mL) EFFECT

1 –5 Analgesia

5 –10 Lightheaded, Tinnitus,

Tongue numbness

10 –15 Seizure, LOC

15 –25 Coma, resp arrest

>25 CV depression

Barash, 5 th pp464

Relative Potency for Toxicity

▪AGENT

(CVS:CNS) Toxicity

▪RELATIVE ▪CVS:CNS

POTENCY

FOR CNS

TOXICITY

Bupivacaine 4 2

L-bupivacaine

Etidocaine

Lidocaine

Mepivacaine

Ropivacaine

Barash, 5 th edition pp462

2.9

2

1

1.4

2.9

2

4.4

7.1

7.1

2

LA Toxicity - CVS

Newer amino amide local anesthetics potential to cause

CNS toxicity

Indicators of CVS toxicity

Mechanism of toxicity

Albright, Anesthesiology,1979

Clarkson, Anesthesiology, 1985

Seizure

30% smaller dose for Bup than others

Dysrhythmia

(a) Bup 13.2 mg/kg

(b) L-Bup

43.7mg/kg

(c) Rop 91.8 mg/kg

Shigeo, Anesth Analg 2001

EKG in CVS Toxicity

Kim, Canadian J of Anesthesia, 2003

Local Anesthetic Toxicity Topics

Local Anesthetic Pharmacology

Adverse Reactions to Local Anesthetics

Types of Toxicity

Acute Systemic Toxicity

Management of Acute Systemic

Toxicity

Early Options to Treat LA Toxicity

Epinephrine and

Atropine

Shock, Shock,

Shock

Other ACLS

Milrinone

Versed

Propofol

CPB

Early Options to Treat LA Toxicity

Figure 1. Lethal dose-response curves for bupivacaine in the presence or absence of verapamil and nimodipine. B = bupivacaine, N + B = nimodipine 200 [micro sign]g/kg + bupivacaine, V + B = verapamil 150 [micro sign]g/kg + bupivacaine.

Adsan, Anesth Analg, 1998

A FRESH IDEA

Lipid Emulsions expand the list of options

A Decade of research and a growing body of evidence and case reports

The Rescue Kit

Weinberg, LipidRescue.com, 2008

First To Benefit from Lipid Emulsion

Promising experiments with LA toxicity and Lipid

Emulsion resuscitation

Success leads to expanded research

Weinberg, Anesthesiology, 1998

Lipid Sink Hypothesis

Lipid infusion

Lipid phase

Highly lipophilic amino amides

Decreased unbound fraction

Weinberg, Anesthesiology, 1998

Studies with Lipid Emulsions in a Dog Model

Group Treatment MAP mmHg

HR PaO2 PaCO2 pH

Saline

Saline

Baseline 91

+/-12

Recovery 10

+/-3

Lipid Baseline 96

+/-14

Lipid Recovery 93

+/-12

122

+/-17

ASYS

128

+/-21

126

+/- 18

236

+/-69

228

+/- 63

212

+/-56

36

+/-2

35

+/-2

36

+/-2

7.38

+/-.04

7.39

+/-.02

7.35

+/- .04

Weinberg et al, Lipid emulsion infusion rescues dogs, 2003

First Lipid Emulsion Resuscitation after

Bupivacaine toxicity/arrest

20 min of advanced cardiac life support, a total of 3 mg epinephrine, given in divided doses, 2 mg atropine, 300 mg amiodarone, and 40 U arginine vasopressin were administered. In addition, monophasic defibrillation was used at escalating energy levels-200, 300, 360, and 360

J, according to the advanced cardiac life support protocol. Cardiac rhythms included ventricular tachycardia with a pulse, pulseless ventricular tachycardia that momentarily became ventricular fibrillation, and eventually asystole. The arrhythmias observed during most of the resuscitation period were pulseless ventricular tachycardia and asystole.

Rosenblatt, Anesthesiology, 2006

Further Case Studies on LE

LipidRescue lists several case reports of successful resuscitation with LE after CVS toxicity with life threatening rhythms or asystole.

Inferior to randomized double-blinded trials but such investigations would clearly be unethical

Not many case studies giving an account of an unsuccessful resuscitation effort with or without

LE although we know such events have occurred

Weinberg, Correspondence, 2008

Applications of Intralipid in ED

Intralipid has been used to treat other types of drug overdose

Case studies are on the Lipidrerscue.org website.

Same lipid sink idea

The Big Question

– Lipid Emulsions are

NO SUBSTITUTE for

ACLS.

– Where do we insert lipid emulsion administration into the

ACLS algorithm?

– How is the drug given?

Weinberg, correspondence, 2008

primum non nocere

Risks of Lipid Emulsion Infusion: all < 1%

Modulation of cytokine production by WBCs

Altered inflammatory response

Weakness, altered MS, seizures in children

Fat emboli if lipid particles >5 microns in diameter

Hyperlipedemia

Pulmonary hypertension anaphylaxis especially if prepared from soybean oil (most likely adverse reaction with acute, short-term administration)

References

Arthur GR: Alterations in the pharmacokinetic properties of amide local anesthetics following local anesthetic induced convulsions. Acta Anaesthesiol Scand 32:522, 1988

Barash P: Clinical Anesthesia, 5 th edition, chapter 17, 2006

Clarkson C: Mechanism for bupivacaine depression of cardiac conduction: fast block of sodium channels during the action potential with slow recovery from block during diastole. Anesthesiology 1985;62:396-405.

Colin J: Intravenous ropivacaine bolus is a reliable marker of intravascular injection in premedicated healthy

Volunteers. Canadian Journal of Anesthesia50: 8 / pp 795 –800, 2003

Cotileas P: Bupivacaine-Induced Myocardial Depression and Pulmonary Edema: A Case Report. Journal of

Electrocardiology Vol. 33 No. 3 2000

Katzung B: Basic & Clinical Pharmacology, 10th Edition, Chapter 26

Kim J: Continuous mixed venous oxygen saturation, not mean blood pressure, is associated with early bupivacaine cardiotoxicity in dogs. Canadian Journal of Anesthesia 50:376-381 (2003)

Mather L: Acute Toxicity of LA: Underlying Pharmacokinetic and Pharmacodynamic Concepts, Regional

Anesthesia and Pain Medicine, Vol 30, No. 6, 2005

Miller R: Miller’s Anesthesia, 6 th Edition, Chapter 14, 2005

Mischa J: The effects of Age on Neural Blockade and Hemodynamic Changes After Epidural Anesthesia with

Ropivacaine. International Anesthesia Research Society, 94(5): 1325-1330, 2002

Morgan and Mikhail, 4 th edition, Chapter 14, 2006

Rosenberg H: maximum Recommended Doses of Local Anesthetics: A multifactorial Concept. American Society of Regional Anesthesia and Pain Medicine, 29 (6):564-575, 2004

ScottD

: EDITORIAL: “Maximum Recommended Doses” of Local Anesthetic Drugs. British Journal of Anesthesia

Vol 63, No. 4, 1989.

Shigeo O: Systemic Toxicity and Resuscitation in Bupivacaine, Levobupivacaine, or Ropivacaine Infused Rats.

Anesth Analg 2001;93:743 –8)

Weinberg G: Lipid emulsion infusion rescues dogs from Bupivacaine induced cardiac toxicity. Regional Anesthesia and Pain Medicine, Vol 28, No 3 :198-202, 2003

Weinberg G: Pretreatment or Resuscitation with a Lipid Infusion Shifts the Dose-Response to Bupivacaineinduced Asystole in Rats. Anesthesiology:Volume 88(4)April 1998pp 1071-1075

Warren J: Reversal of Central Nervous System and Cardiac Toxicity After Local Anesthetic Intoxication by Lipid

Emulsion Injection. International Anesthesia Research Society, Volume 106(5):1578-1580, 2008

Yokoyama M: Effect of Vasoconstrictive Agents added to lidocaine on IV lidocaine-induced convulsions in rats.

Anesthesiology 82:574,1995

Download